The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1979, 122: 2498-2504.
Copyright © 1979 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, R. H.
Right arrow Articles by Saxon, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Stevens, R. H.
Right arrow Articles by Saxon, A.

Characterization of a Circulating Subpopulation of Spontaneous Antitetanus Toxoid Antibody Producing B Cells Following in Vivo Booster Immunization1

Ronald H. Stevens, Eric Macy, Casey Morrow and Andrew Saxon

From the Department of Microbiology and Immunology and the Department of Medicine, UCLA School of Medicine, Los Angeles, California 90024

Abstract

The appearance of circulating B lymphocyte subpopulations responsible for the in vitro synthesis of IgG or IgM antitetanus toxoid antibody after in vivo booster immunization has been analyzed. Before booster immunization, only background levels of IgG antitetanus toxoid antibody were synthesized by B lymphocytes alone, or in combination with T cells and pokeweed mitogen, as measured by quantitative radioimmunoassay. Within 5 days after booster immunization, a population of B lymphocytes appeared within the circulation that had the capacity to synthesize IgG antitetanus toxoid antibody in the absence of T lymphocytes or pokeweed mitogen. These cells could be detected in the circulation until 10 to 12 days after immunization, and the antibody synthesized was inhibited by the inclusion of 50 µg/ml cyclohexamide in the culture medium. At the peak of this response, between 10 and 60% of the total IgG synthesized was IgG directed against tetanus toxoid. The cells responsible had a precursor frequency of up to 10-3 in the non-E-rosetting cell fraction obtained from peripheral blood and sedimented at 1 x G with velocities ranging from 4 to 11 mm/hr. The synthesis of IgM antitetanus toxoid antibody by this cell fraction was not detected.

In contrast to the above B cells, lymphocytes capable of responding to pokeweed mitogen and T lymphocytes with the synthesis of IgG antitetanus toxoid antibody did not appear in the circulation until 10 days after immunization. Limiting dilution analysis of the pokeweed mitogen responsive B lymphocytes 2 to 4 weeks after booster immunization gave a precursor frequency of 1 x 10-4. In the presence of T cells and PWM, the synthesis of IgM anti-Tet remained at constant levels before and for 3 weeks post-booster immunization. These results indicate that multiple subsets of circulating B cells can be functionally defined in humans.

Footnotes

1 This work was supported by National Cancer Institute Grant CA 12800, NIAID Center for Interdisciplinary Research in Immunologic Disease Grant AI 15322 and National Foundation, March of Dimes Grant 6-147. A. S. is the recipient of an Allergic Diseases Academic Award AI 00326-01 NIAID. E. M. is a recipient of NIH training fellowship GM-7185-04.




This article has been cited by other articles:


Home page
BloodHome page
I. Gonzalez-Garcia, B. Rodriguez-Bayona, F. Mora-Lopez, A. Campos-Caro, and J. A. Brieva
Increased survival is a selective feature of human circulating antigen-induced plasma cells synthesizing high-affinity antibodies
Blood, January 15, 2008; 111(2): 741 - 749.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Gonzalez-Garcia, E. Ocana, G. Jimenez-Gomez, A. Campos-Caro, and J. A. Brieva
Immunization-Induced Perturbation of Human Blood Plasma Cell Pool: Progressive Maturation, IL-6 Responsiveness, and High PRDI-BF1/BLIMP1 Expression Are Critical Distinctions between Antigen-Specific and Nonspecific Plasma Cells
J. Immunol., April 1, 2006; 176(7): 4042 - 4050.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Odendahl, H. Mei, B. F. Hoyer, A. M. Jacobi, A. Hansen, G. Muehlinghaus, C. Berek, F. Hiepe, R. Manz, A. Radbruch, et al.
Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response
Blood, February 15, 2005; 105(4): 1614 - 1621.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
F Medina, C Segundo, A Campos-Caro, I Salcedo, A Garcia-Poley, and J A Brieva
Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells
Gut, March 1, 2003; 52(3): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Zhan, E. Tian, K. Bumm, R. Smith, B. Barlogie, and J. Shaughnessy Jr
Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development
Blood, February 1, 2003; 101(3): 1128 - 1140.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Medina, C. Segundo, A. Campos-Caro, I. Gonzalez-Garcia, and J. A. Brieva
The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression
Blood, March 15, 2002; 99(6): 2154 - 2161.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Sampalo, G. Navas, F. Medina, C. Segundo, C. Camara, and J. A. Brieva
Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction
Blood, November 1, 2000; 96(9): 3168 - 3174.
[Abstract] [Full Text] [PDF]


Home page
Genome Res.Home page
H H Hogrefe and B Shopes
Construction of phagemid display libraries with PCR-amplified immunoglobulin sequences.
Genome Res., October 1, 1994; 4(2): S109 - S122.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.